Eye Scan For Diabetes! Berkshire Startup Is Developing Revolutionary Medical Technology With £2.85M Funding
Amount Raised
£2.85 Million
Round Type
Seed
Description
The repetitive finger stick blood testing with all the pain, discomfort and inconvenience that brings for people suffering from diabetes might become a thing of the past very soon. A ground-breaking device that will allow the 4.7 million people in the UK with diabetes to monitor their blood-sugar levels through a simple scan of the eye is about to see the light of the day. The Berkshire-based startup Occuity has received investment funding to forge ahead with its development of the Occuity Indigo, the extremely innovative non-contact, optical glucose meter.
Who to call at Berkshire Residential Investments, and when
A new round usually means Berkshire Residential Investments is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Berkshire Residential Investments raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Berkshire Residential Investments, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Berkshire Residential Investments. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Berkshire Residential Investments raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Berkshire Residential Investments raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.